Unable to load price data. Sorry.

¯\_(ツ)_/¯

Replidyne, Inc. (NASDAQ:RDYN.DL)

CAPS Rating: No stars

The Company is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RDYN.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

NetscribeBiotech (94.69)
Submitted March 19, 2007

Replidyne, Inc. is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing anti-infective products. As of now it doesn’t have any product in the market. Thus the company is in its developing phase and it may… More

NASDAQ:RDYN.DL VS S&P 500 (SPY)

NASDAQ:RDYN.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about RDYN.DL.

No one has written a Pitch for RDYN.DL stock yet. Tell us why you think RDYN.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in RDYN.DL.

No players have picked RDYN.DL yet. Tell us why you think RDYN.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackSoros 84.45 9/30/2007 Outperform NS $6.46 -87.93% -49.62% -38.31 2/26/2009 @ $0.78 1 Comment
TrackCowenandCo 75.85 9/8/2006 Outperform NS $9.75 -92.00% -40.91% -51.09 2/26/2009 @ $0.78 0 Comment

Advertisement